$TRU Balance Sheet | Understand Stock

$TRU

$79.62 -$1.86 (2.28%) Close

$TRU Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q3 FY2026 As of Sep 30, 2026	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021
Assets
Current assets:
Cash and cash equivalents
Trade accounts receivable, net of allowance of $26.9 and $27.7
Other current assets
Current assets of discontinued operations
Total current assets

Property, plant and equipment, net of accumulated depreciation and amortization of $571.4 and $545.0
Goodwill
Other intangibles, net of accumulated amortization of $3,027.1 and $2,716.3
Other assets
Other assets of discontinued operations
Total assets

Liabilities and stockholders’ equity
Current liabilities:
Trade accounts payable
Current portion of long-term debt
Other current liabilities
Current liabilities of discontinued operations
Total current liabilities

Long-term debt
Deferred taxes
Other liabilities
Other liabilities of discontinued operations
Total liabilities
Stockholders’ equity:
Preferred stock, $0.01 par value; 100.0 million shares authorized; none issued or outstanding as of September 30, 2026 and December 31, 2025, respectively
Common stock, $0.01 par value; 1.0 billion shares authorized at September 30, 2026 and December 31, 2025, 198.5 million and 199.4 million shares issued at September 30, 2026 and December 31, 2025, respectively, and 190.7 million and 192.4 million shares outstanding as of September 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Treasury stock at cost; 7.7 million and 7.0 million shares at September 30, 2026 and December 31, 2025, respectively
Retained earnings
Accumulated other comprehensive loss
Total TransUnion stockholders’ equity
Noncontrolling interests
Total stockholders’ equity
Total liabilities and stockholders’ equity

Comments